Afya Limited

What they do

Afya operates a network of post-secondary education institutions in Brazil focused primarily on medicine and other health-related programs, as evidenced by entities such as Instituto Tocantinense Presidente Antônio Carlos S.A. (ITPAC) and Centro de Ciências em Saúde de Itajubá S.A. (CCSI). The company also holds technology and service assets including iClinic, Medicinae, Medical Harbour, Cliquefarma, Shosp, RXPRO, Glic, and Unidom. Its operations are organized through numerous Brazilian subsidiaries, each associated with specific campuses or digital products.

Revenue drivers

• Medical and health sciences education — Tuition revenue from undergraduate and graduate programs delivered through subsidiaries such as ITPAC Porto, ITPAC Araguaína, UNIVACO, IPTAN, IESVAP, CCSI, IESP, FADEP, FASA, IPEC, UniRedentor, UniSL, FESAR, and FCMPB; this is the core revenue source.
• Digital health and practice management software — Subscription and service revenue from iClinic, Medicinae, RXPRO, and Shosp, which provide software and technology to healthcare professionals and organizations.
• Medical equipment and technology services — Revenue from Medical Harbour, which supplies medical and hospital equipment and related technology services.
• Pharmacy and telemedicine platforms — Revenue from Cliquefarma (online drugstore) and Glic (telemedicine systems), extending Afya's presence into pharmacy retail and virtual care.

Recent performance

The filing excerpt does not contain revenue, earnings, or student enrollment figures, only a list of subsidiaries and equity components. Financial statements are indicated for 2023, 2024, and 2025 periods, but no numerical results are shown in the provided text. The only specific event mentioned is the acquisition of Faculdade Masterclass Ltda. on May 7, 2025. No other performance data can be cited from the source material.

Strategy

Afya's strategy appears to be consolidation of health education institutions and expansion into digital health services, as seen in its portfolio of education subsidiaries alongside technology assets like iClinic, Medicinae, and Shosp. The May 2025 acquisition of Faculdade Masterclass Ltda. indicates continued bolt-on acquisitions. The mix of education and technology entities suggests a focus on integrating clinical practice tools with medical education and service delivery. No forward-looking guidance or capital allocation plans are provided in the excerpt.

Risks

• Regulatory and accreditation risk — As a Brazilian post-secondary education provider, Afya's operations are subject to Ministry of Education regulations and program-specific accreditation that can affect enrollment and tuition.
• Integration risk from acquisitions — The company has numerous subsidiaries acquired over time, including the May 2025 purchase of Faculdade Masterclass Ltda., creating complexity in integrating operations and realizing synergies.
• Concentration in Brazilian healthcare education — Revenue is concentrated in Brazil's medical and health sciences education market, exposing results to changes in student demand, tuition pricing, and competition from other private institutions.
• Digital services execution risk — Afya's expansion into software and telemedicine through iClinic, Medicinae, RXPRO, Glic, and others requires technological investment and may face competition from established health tech providers.

Outlook

The excerpt does not contain management's forward-looking statements or guidance. No outlook can be provided based on the available filing text.